| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 08/24/2006 | US20060188576 Pirenzepine ophthalmic gel |
| 08/24/2006 | US20060188574 Controlled release lipoic acid |
| 08/24/2006 | US20060188571 Mixing progesterone with water and adjuvants; drying; compaction |
| 08/24/2006 | US20060188560 Delivery system for nucleic acids |
| 08/24/2006 | US20060188557 Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor |
| 08/24/2006 | US20060188554 Transdermal absorption preparation |
| 08/24/2006 | US20060188548 Satiety promoting beverage and use in a diet to moderate food consumption |
| 08/24/2006 | US20060188534 Dispersions for the formulation of slightly or poorly soluble agents |
| 08/24/2006 | US20060188532 Particularly drugs and cosmetic agents; an ethoxylated oil having between 10 and 19 ethoxy units, and the delivered agent, especially analgesics, antiinflammatory agents or antiwrinkle agents; improved penetration and bioavailability |
| 08/24/2006 | US20060188531 Particularly drugs and cosmetic agents; an ethoxylated oil, fatty acid, fatty alcohol, or fatty amine having between 10 and 19 ethoxy units, and the delivered agent, especially analgesics, antiinflammatory agents or antiwrinkle agents; improved penetration and bioavailability |
| 08/24/2006 | US20060188525 Relieving spastic muscle pain; ultrasonic frequency disruption of stratum corneum and applying patch containing neurotoxin |
| 08/24/2006 | US20060188473 Compositions and methods for repressing B cell autoantibody secretion and for treating autoimmune disorders |
| 08/24/2006 | US20060188472 HAS-active ingredient conjugates |
| 08/24/2006 | US20060188437 Isolation of a cell-specific internalizing peptide that infiltrates tumor tissue for targeted drug delivery |
| 08/24/2006 | CA2836652A1 Production method of capsinoid by dehydrating condensation, stabilizing method of capsinoid, and capsinoid composition |
| 08/24/2006 | CA2601745A1 Insulinotropic agents conjugated with structurally well defined branched polymers |
| 08/24/2006 | CA2598522A1 Human monoclonal antibodies to prostate specific membrane antigen (psma) |
| 08/24/2006 | CA2598364A1 Composition containing chitosan for sustained drug release |
| 08/24/2006 | CA2598316A1 Polyoxyalkylene chain-containing lipid derivative and lipid film structure containing such derivative |
| 08/24/2006 | CA2598239A1 Nanoparticulate formulations of taxanes and carrier proteins for use in combination chemotherapy |
| 08/24/2006 | CA2597958A1 Aprotinin polypeptides for transporting a compound across the blood-brain barrier |
| 08/24/2006 | CA2597925A1 Use of human hemojuvelin product to regulate hepcidin-mediated iron metabolism |
| 08/24/2006 | CA2597638A1 Methods for treating cancer using an immunotoxin comprising an exotoxin a moiety having a furin cleavage site replaced with a cancer-associated protease site cleaved by mmp-2 or mmp-9 |
| 08/24/2006 | CA2597525A1 Solid ophthalmic drug for external use |
| 08/24/2006 | CA2597367A1 Glucose oxidase formulations and methods for making and using them |
| 08/24/2006 | CA2597020A1 Inhibitor peptides |
| 08/24/2006 | CA2595620A1 Compositions for treatment of diseases of the nail unit |
| 08/24/2006 | CA2595581A1 Sustained release composition of protein drug |
| 08/24/2006 | CA2594666A1 Use of activated polymers for separation of protein and polypeptide multimers |
| 08/23/2006 | EP1693458A1 Intracellular inhibitory peptides |
| 08/23/2006 | EP1693073A2 Wound dressings comprising hydrated hydrogels and enzymes |
| 08/23/2006 | EP1693071A2 Covalently-linked active complexes , from which an active agent is released by stress-activated skin enzymes |
| 08/23/2006 | EP1693054A2 Lactic acid polymer and process for producing the same |
| 08/23/2006 | EP1693053A2 Steroid solution aerosol products with enhanced chemical stability |
| 08/23/2006 | EP1692951A1 Topical antifungal composition |
| 08/23/2006 | EP1692318A2 Compositions and methods to diagnose and treat lung cancer |
| 08/23/2006 | EP1692279A2 Preservative-containing virus formulations |
| 08/23/2006 | EP1691846A1 Peptides whose uptake by cells is controllable |
| 08/23/2006 | EP1691841A2 Compositions comprising two different populations of polymer-active agent conjugates |
| 08/23/2006 | EP1691840A2 Psma formulations and uses thereof |
| 08/23/2006 | EP1691826A1 Excipients in drug delivery vehicles |
| 08/23/2006 | EP1691825A1 Stabilized interferon liquid formulations |
| 08/23/2006 | EP1691795A2 Pharmaceutical compositions comprising danazol |
| 08/23/2006 | EP1691785A1 Excipients in drug delivery vehicles |
| 08/23/2006 | EP1691784A1 Biodegradable triblock copolymers as drugs solubilizing agents and method of use |
| 08/23/2006 | EP1691780A2 Gene delivery mediated by liposome-dna complex with cleavable peg surface modification |
| 08/23/2006 | EP1691746A2 Mucoadhesive drug delivery devices and methods of making and using thereof |
| 08/23/2006 | EP1691718A1 Therapeutic microparticles |
| 08/23/2006 | EP1691715A2 Surfactant-based gel as an injectable, sustained drug delivery vehicle |
| 08/23/2006 | EP1691664A2 Antibodies and/or conjugates thereof which bind to the amino terminal fragment of urokinase, compositions and uses thereof |
| 08/23/2006 | EP1691661A2 Soluble tcr molecules and methods of use |
| 08/23/2006 | EP1562634B1 Positional isomers of pegylated interferon alpha 2a |
| 08/23/2006 | EP1515740B1 Aqueous preparation containing oligopeptides and etherified cyclodextrin |
| 08/23/2006 | EP1507794B1 Novel multimeric molecules, the preparation method thereof and use of same for the preparation of medicaments |
| 08/23/2006 | EP1441785A4 Improved method for generating an aerosol |
| 08/23/2006 | EP1432414B1 Nail varnish containing tazarotene and use thereof for treating and/or preventing psoriasis |
| 08/23/2006 | EP1402913B1 Dry powder inhalation system for transpulmonary administration, method of manufacturing a dry powdered preparation, and use of a freeze dried composition |
| 08/23/2006 | EP1399501B1 Negatively charged amphiphilic block copolymer as drug carrier and complex thereof with positively charged drug |
| 08/23/2006 | EP1385528B1 Disinfecting and solubilizing steroid compositions |
| 08/23/2006 | EP1383375B1 A release pharmaceutical construct for gastric retention |
| 08/23/2006 | EP1373376B1 Hydrogel attached to backing and method for making same |
| 08/23/2006 | EP1358318B1 Hybridoma cell line g250 and its use for producing monoclonal antibodies |
| 08/23/2006 | EP1339294B1 Nutritional composition for an immune condition |
| 08/23/2006 | EP1292612B1 Glycopeptide phosphonate derivatives |
| 08/23/2006 | EP1280849B1 Process for the preparation of proteinbased hydrogels |
| 08/23/2006 | EP1261330B1 Method for increasing intestinal absorption of fat soluble vitamins in post-menopausal women and in lower animals |
| 08/23/2006 | EP1240337B1 Methods and compositions for prolonging elimination half-times of bioactive compounds |
| 08/23/2006 | EP1237537B1 Composition in the form of a gel for receiving an active ingredient in a solution or suspension, especially for application on a mucous membrane and method of production thereof |
| 08/23/2006 | EP1212058B1 Topical treatment for prevention of ocular infections |
| 08/23/2006 | EP1037673B1 Charged lipids and uses for the same |
| 08/23/2006 | EP0998916B1 Medicinal compositions for application to mucosa |
| 08/23/2006 | CN1823091A 功能性淀粉粉末 Functional starch powder |
| 08/23/2006 | CN1822860A Conjugated biological molecules and their preparation |
| 08/23/2006 | CN1822859A Self-emulsifying and self-microemulsifying formulations for the oral administration of taxoids |
| 08/23/2006 | CN1822858A Stable non-dihydrate azithromycin oral suspensions |
| 08/23/2006 | CN1822844A Glycoside-containing liposome |
| 08/23/2006 | CN1822842A Solid pharmaceutical preparation |
| 08/23/2006 | CN1822831A Semi-solid systems containing azetidine derivatives |
| 08/23/2006 | CN1822830A Emulsifying systems containing azetidine derivatives |
| 08/23/2006 | CN1822819A Oral controlled release forms useful for reducing or preventing nicotine cravings |
| 08/23/2006 | CN1822814A Sustained release dosage forms of anesthetics for pain management |
| 08/23/2006 | CN1822765A Delivery of compounds with rehydrated blood cells |
| 08/23/2006 | CN1821313A Zinc-ferrit pigments stable against reduction, method for making and use of said pigments |
| 08/23/2006 | CN1271116C Lipid-polymer-conjugates |
| 08/23/2006 | CN1271115C Poly glycol long chain fatty alkyl maleimide derivative and its medicinal combination |
| 08/23/2006 | CN1271086C GLP-1 derivs. |
| 08/23/2006 | CN1270779C Medicament protecting agent capable of resisting cold, increasing dissolution and resisting oxidation and method of preparation the same |
| 08/23/2006 | CN1270778C Test system for evaluating the compatibility of biologically active substances with copolymers |
| 08/23/2006 | CN1270777C Addition agent of pyrithioxine hydrochloride utilized for injection |
| 08/23/2006 | CN1270774C Therapeutic application of chimeric and radiolabeled antibodies to human B lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 08/23/2006 | CN1270725C Inorganic nitrite and organic acid in combination as topical antiviral composition |
| 08/23/2006 | CN1270714C Microemulsion preconcentrates containing piperidine substance P antagonist |
| 08/23/2006 | CN1270698C Preparation method of liposome with high encapsulating rate to water soluble medicine |
| 08/23/2006 | CN1270697C Method of preparation oral nano nourishing emulsion |
| 08/22/2006 | US7094884 A protein containing an amyloid beta (A beta ) peptide, a peptidyl prolyl isomerase chaperone,wherein the PrP and the peptidyl prolyl isomerase chaaperone are covalently linked, and such protein is soluble to at least 100 nM in a solution with a pH of 7.4 contains 20 nM sodium phosphate and 150 nM NaCl |
| 08/22/2006 | US7094880 Decorin proteoglycan inhibitor of fibrinogen blood clotting |
| 08/22/2006 | US7094872 Activated polyethylene glycol esters |
| 08/22/2006 | US7094831 Polymerization of vinyl acetate polymer in presenc eof free radical catalyst |
| 08/22/2006 | US7094810 pH-sensitive block copolymers for pharmaceutical compositions |
| 08/22/2006 | US7094804 Water free ubiquinone concentrate |